SNGX News and Press, Soligenix Inc. From 05/10/21

Soligenix (SNGX) is trading sharply lower after the company announced its decision not to pursue a rolling submission for its marketing application of HyBryte (SGX301) in the treatment of cutaneous T-cell lymphoma ((CTCL)).After discussions with the FDA, “the company decided ...

Gainers: Protagenic Therapeutics (PTIX) +44%, Cue Biopharma CUE +36%, Obalon Therapeutics (OBLN) +28%, Soliton SOLY +24%, Precipio (PRPO) +20%.Losers: Insmed INSM -17%, Soligenix (SNGX) -17%, Kodiak Sciences (KOD) -14%, Dynavax ...

Soligenix (SNGX) -22% as company now plans to submit the NDA in the 1H22.LM Funding America (LMFA) -11%.Senmiao Technology (AIHS) -7%.InnSuites Hospitality (IHT) -5%.Ra Medical Systems (RMED) -6%.Galapagos (GLPG) -5%.Stealth BioTherapeutics (MITO) -5%.Luokung Technology (LKCO) -5%. For...

HyBryte™ Awarded Innovation Passport in the United Kingdom PR Newswire PRINCETON, N.J. , May 10, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializin...

Broad Efficacy and Improved Safety Profile of HyBryte™ Presented at Society for Investigative Dermatology Virtual Meeting PR Newswire PRINCETON, N.J. , May 4, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage...

Soligenix Presents at the National Foundation for Infectious Diseases Annual Conference on Vaccinology Research COVID-19 Vaccine Program Demonstrates Immunogenicity In Non-Human Primates PR Newswire PRINCETON, N.J. , April 28, 2021 /PRNewswire/ -- Solige...

HyBryte™ Expanded Efficacy and Safety Data Presented at the American Academy of Dermatology Meeting PR Newswire PRINCETON, N.J. , April 26, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical compa...

Soligenix Announces Presentations at Prominent Scientific Conferences Key Data Outcomes Presented for HyBryte™ and CiVax™ PR Newswire PRINCETON, N.J. , April 13, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company)...

Soligenix Receives Conditional FDA Acceptance of Proposed Brand Name HyBryte™ for SGX301 in CTCL PR Newswire PRINCETON, N.J. , April 7, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical comp...

Soligenix (SNGX): FY GAAP EPS of -$0.64 misses by $0.10.Revenue of $2.4M (-47.8% Y/Y) beats by $0.2M.Shares +4.03% PM.Press Release For further details see: Soligenix EPS misses by $0.10, beats on revenue